Hepatozelluläres Karzinom

Shin HD et. al. (2003) Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma.

Yong KJ et al. (2013) Oncofetal gene SALL4 in aggressive hepatocellular carcinoma.

Hopkins LJ et al. (2013) Oncofetal gene SALL4 in aggressive hepatocellular carcinoma.

Suzuki E et al. (2013) Oncofetal gene SALL4 in aggressive hepatocellular carcinoma.

Masuda S et al. (2013) Oncofetal gene SALL4 in aggressive hepatocellular carcinoma.

Kishnani PS et al. (2009) Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease.

Napoli VM et al. (1977) Hepatoblastoma in infant sister and brother.

Shen FM et al. (1991) Complex segregation analysis of primary hepatocellular carcinoma in Chinese families: interaction of inherited susceptibility and hepatitis B viral infection.

Buetow KH et al. (1989) Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma.

Pasquinelli C et al. (1988) Rearrangement of a common cellular DNA domain on chromosome 4 in human primary liver tumors.

Henderson AS et al. (1988) Identification of a chromosomal aberration associated with a hepatitis B DNA integration site in human cells.

Zhou YZ et al. (1988) Structural analysis of a hepatitis B virus genome integrated into chromosome 17p of a human hepatocellular carcinoma.

Blanquet V et al. (1988) Regional mapping to 4q32.1 by in situ hybridization of a DNA domain rearranged in human liver cancer.

Wang HP et al. (1988) Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas.

Rogler CE et al. (1985) Deletion in chromosome 11p associated with a hepatitis B integration site in hepatocellular carcinoma.

Fisher JH et al. (1987) Sequences which flank an 11p deletion observed in an hepatocellular carcinoma map to 11p13.

Ito E et al. (1987) Type 1a glycogen storage disease with hepatoblastoma in siblings.

Hagstrom RM et al. (1968) Primary hepatocellular carcinoma in three male siblings.

Fraumeni JF et al. (1969) Hepatoblastoma in infant sisters.

Denison EK et al. (1971) Familial hepatoma with hepatitis-associated antigen.

Lynch HT et al. (1984) Familial hepatocellular carcinoma in an endemic area of Thailand.

Chang MH et al. (1984) Fraternal hepatocellular carcinoma in young children in two families.

McGlynn KA et al. (1995) Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1.

Oda H et al. (1996) Somatic mutations of the APC gene in sporadic hepatoblastomas.

Agarwal VR et al. (1998) Molecular basis of severe gynecomastia associated with aromatase expression in a fibrolamellar hepatocellular carcinoma.

Schwienbacher C et al. (2000) Gain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas.

Taniguchi K et al. (2002) Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.

Thorgeirsson SS et al. (2002) Molecular pathogenesis of human hepatocellular carcinoma.

Ye QH et al. (2003) Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning.

KAPLAN L et al. (1965) FRATERNAL PRIMARY HEPATOCELLULAR CARCINOMA IN THREE MALE, ADULT SIBLINGS.

Lee JW et al. (2005) PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas.

Chiu CM et al. (2007) Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level.

Tanabe KK et al. (2008) Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis.

Yoo BK et al. (2009) Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression.

Hill-Baskin AE et al. (2009) Diet-induced hepatocellular carcinoma in genetically predisposed mice.

Yoo BK et al. (2009) Identification of genes conferring resistance to 5-fluorouracil.

Ji J et al. (2009) MicroRNA expression, survival, and response to interferon in liver cancer.

Zhang H et al. (2010) Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers.

Kumar V et al. (2011) Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma.

Li M et al. (2011) Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma.

Huang J et al. (2012) Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma.

Honeyman JN et al. (2014) Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma.

OMIM.ORG article

Orphanet article